[茶喘平——一种苏联新型长效茶碱剂型——在支气管哮喘患者中的药代动力学]
[The pharmacokinetics of theopek--a new Soviet prolonged-action drug form of theophylline--in patients with bronchial asthma].
作者信息
Belousov Iu B, Abazova F I, Kholodov L E, Chervinskaia T A, Sokolov A V
出版信息
Farmakol Toksikol. 1989 Sep-Oct;52(5):63-8.
PMID:2599082
Abstract
Pharmacokinetics of theopek--a new original slow release formulation of theophylline--as compared with theotard and theodur was studied in patients with bronchial asthma. The pharmacokinetic parameters of this product were shown to be comparable. A significant correlation between blood theophylline concentration and the bronchodilating and diuretic effects in patients with bronchial asthma was revealed.
摘要
在支气管哮喘患者中研究了茶喘平（一种新的茶碱缓释制剂）与茶喘宁和氨茶碱相比的药代动力学。结果显示该产品的药代动力学参数具有可比性。研究还揭示了支气管哮喘患者血中茶碱浓度与支气管扩张和利尿作用之间存在显著相关性。
Zotero 插件